Effects of the Consumption of Test Foods on Allergic Reactions of the Nose and Eyes Caused by Allergens

Not Applicable

• Conditions: Healthy Japanese subjects and subjects with mild symptoms

• Registration Number: JPRN-UMIN000038765
• Lead Sponsor: ORTHOMEDICO Inc.

Brief Summary

Yamada S, Shirai M, Inaba Y, Takara T. Effects of repeated oral intake of the quercetin-containing supplement on allergic reaction-Randomized, placebo-controlled, double-blind parallel-group study-. Jpn Pharmacol Ther. 2020; 48(11): 1945-1959

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-04-04
• Study Start: 2020-07-31
• Results First Posted: 2020-11-27
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects undergoing medical treatment or having a medical history of malignant tumor, heart failure, or myocardial infarction 2. Subjects carrying a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage as part of their daily intake 5. Subjects receiving long-term drug treatment (Antiallergic drugs, antihistamines, steroids, vasoconstrictors, antihypertensives, etc.) that may affect allergic symptoms of the nose and eyes during the trial 6. Subjects currently regularly taking medications (including herbal medicines) and supplements 7. Subjects allergic to medications and/or the test-food-related products 8. Subjects who cannot take the test food with the prescribed amount and ingestion method 9. Subjects who are planning to go abroad during this trial 10. Subjects who have a nasal irrigation habit 11. Subjects who are lactating, pregnant, or intending to become pregnant 12. Subjects who have been enrolled in other clinical trials within the last three months before the invitation to participate in this trial, or plan to participate in another trial during this trial 13. Subjects who are judged by the physician as ineligible to participate in the trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified